Covidien (Dublin, Ireland) reported the release of the results from the Solitaire FR Thrombectomy for Acute Revascularization (STAR) study. The two-year study evaluated the safety and efficacy of the Solitaire FR revascularization device in the treatment of acute ischemic stroke (AIS).